SCHEMBL17574538

SCHEMBL17574538

NC(=O)C[CH]c1ccc(Cl)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.43
ADRA2A P08913 2/20 0.41
ADRA2B P18089 2/20 0.41
ADRA2C P18825 2/20 0.41
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 2/20 0.39
SIRT6 Q8N6T7 1/20 0.39
NFE2L2 Q16236 4/20 0.39
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
EPHX1 P07099 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PIK3CD O00329 1/20 0.35
KCNQ3 O43525 2/20 0.35
KCNQ2 O43526 2/20 0.35
KCNE1 P15382 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14480158 0.79 NAPRT (0.47) NAPRTADRA2AADRA2BADRA2CNPC1
SCHEMBL2674302 0.79 ADRA2A (0.41) ADRA2AADRA2BADRA2CHTTALDH1A1
SCHEMBL3466042 0.79 ALDH1A1 (0.33) ALDH1A1
SCHEMBL2675925 0.77 HSD17B10 (0.48) NPC1ALDH1A1MAPTL3MBTL1
SCHEMBL3465340 0.76 RECQL (0.41) ALDH1A1NFE2L2EPHX1L3MBTL1
SCHEMBL15157380 0.75 ALDH1A1 (0.41) ALDH1A1KMT2ATDP1L3MBTL1
SCHEMBL29612143 0.75 NFE2L2 (0.45) NAPRTADRA2AADRA2BADRA2CNPC1
SCHEMBL15156965 0.75 TRPV4 (0.42) KMT2APIK3CDKCNQ3KCNQ2
SCHEMBL14759165 0.75 NNMT (0.54) NPC1HTTRAB9AALDH1A1SIRT6
SCHEMBL15157644 0.75 AR (0.38) NPC1RAB9AALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884860-B2 Fused pyrroledicarboxamides and their use as pharmaceuticals SANOFI (FR) 2018-02-06 US disclosed
US-20160159793-A1 Fused Pyrroledicarboxamides and Their Use as Pharmaceuticals SANOFI (FR) 2016-06-09 US disclosed
US-9284333-B2 Fused pyrroledicarboxamides and their use as pharmaceuticals SANOFI (FR) 2016-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159793-A1 Fused Pyrroledicarboxamides and Their Use as Pharmaceuticals KCNA1, KCNE1, KCNH1 NAPRT 1800/4885ADRA2A 2968/4885ADRA2B 2970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.